Harvest CSI Vaccine and Biotechnology ETF (SHA:562860)

Assets	210.99M
Expense Ratio	0.60%
PE Ratio	31.03
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	-9.81%

Volume	24,363,500
Open	0.6700
Previous Close	0.6690
Day's Range	0.6680 - 0.6850
52-Week Low	0.5710
52-Week High	0.7710
Beta	0.40
Holdings	72
Inception Date	Feb 16, 2023

About 562860

562860.SS was created on 2023-02-16 by Harvest Funds. The fund's investment portfolio concentrates primarily on health care equity. The fund conducts passive index investment, closely tracks the underlying index, pursues the minimization of tracking deviation and tracking error, and strives to have the absolute value of the daily average tracking deviation not exceed 0.2%, and the annualized tracking error not exceed 2%

• Asset Class: Equity
• Category: Health Care
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 562860
• Provider: Harvest Funds
• Index Tracked: CSI Vaccine and Biotechnology Index - CNY - Benchmark TR Gross

Performance

562860 had a total return of -9.81% in the past year, including dividends. Since the fund's inception, the average annual return has been -10.07%.

Top 10 Holdings

46.43% of assets

Name	Symbol	Weight
Walvax Biotechnology Co., Ltd.	300142	9.70%
Chongqing Zhifei Biological Products Co., Ltd.	300122	6.53%
Chengdu Olymvax Biopharmaceuticals Inc.	688319	5.83%
Liaoning Cheng Da Co., Ltd.	600739	4.31%
Sichuan Biokin Pharmaceutical Co.,Ltd.	688506	3.93%
RemeGen Co., Ltd.	688331	3.68%
Shenzhen Kangtai Biological Products Co., Ltd.	300601	3.55%
Shanghai Junshi Biosciences Co., Ltd.	688180	3.23%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.	600196	2.86%
Gan & Lee Pharmaceuticals.	603087	2.80%

Data Sources: S&P Global Market Intelligence and Finnhub

Historical data is provided by S&P Global Market Intelligence. Several fund data points are also provided by Finnhub.

Last checked:

Sep 23, 2026

Data Sources Report a data error